News
AKYA
3.130
-2.49%
-0.080
Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates
NASDAQ · 6h ago
Akoya Biosciences reports Q3 EPS (21c), consensus (20c)
TipRanks · 7h ago
Akoya Biosciences lowers FY24 revenue view to $80M-$85M, consensus $98.19M
TipRanks · 7h ago
*Akoya Biosciences Cuts FY24 View To Rev $80M-$85M >AKYA
Dow Jones · 7h ago
*Akoya Biosciences Cites Persistent Macro Challenges >AKYA
Dow Jones · 7h ago
AKOYA BIOSCIENCES INC <AKYA.O> Q3 SHR VIEW $-0.20 -- LSEG IBES DATA
Reuters · 7h ago
AKOYA BIOSCIENCES INC <AKYA.O> FY2024 REV VIEW $98.2 MLN -- LSEG IBES DATA
Reuters · 7h ago
AKOYA BIOSCIENCES Q3 REVENUE USD 18.8 MILLION VS. IBES ESTIMATE USD 25.4 MILLION
Reuters · 7h ago
*Akoya Biosciences 3Q Loss/Shr 21c >AKYA
Dow Jones · 7h ago
*Akoya Biosciences 3Q Rev $18.8M >AKYA
Dow Jones · 7h ago
Earnings Scheduled For November 14, 2024
Benzinga · 20h ago
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue Estimates
NASDAQ · 1d ago
Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates
NASDAQ · 2d ago
Is Akoya Biosciences (NASDAQ:AKYA) Using Too Much Debt?
Simply Wall St · 2d ago
Weekly Report: what happened at AKYA last week (1104-1108)?
Weekly Report · 3d ago
Akoya Biosciences unveils new era in spatial content innovation
TipRanks · 11/05 13:16
Weekly Report: what happened at AKYA last week (1028-1101)?
Weekly Report · 11/04 09:01
Weekly Report: what happened at AKYA last week (1021-1025)?
Weekly Report · 10/28 09:00
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
Barchart · 10/28 07:30
Weekly Report: what happened at AKYA last week (1014-1018)?
Weekly Report · 10/21 09:00
More
Webull provides a variety of real-time AKYA stock news. You can receive the latest news about Akoya Biosciences, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About AKYA
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).